COVID-19: Investors find new ways to drive positive social outcomes
- The COVID-19 pandemic has put corporate ESG practices in the spotlight. Fresh attention has fallen on social issues such as public health, human capital management and societal inequalities
- This has led more stakeholders to ask how investments can be made with positive social outcomes and impacts
- In this paper, we look at the various approaches AXA IM has adopted to help our clients achieve these objectives
- We believe investors can drive positive social outcomes through investment in different asset classes and can deliver impact through engagement and voting
The COVID-19 pandemic has become a test of companies’ sustainability credentials. It has served to sharpen public and investor scrutiny of environmental, social and governance (ESG) practices and we have observed that this has particularly involved a more intense focus on the ‘social’ component.
It should be no great surprise. The social pillar in ESG includes a wide range of issues that came to the fore as the effects of the virus and accompanying lockdown measures took hold. The pandemic has exposed concerns about employee treatment, supply chain management, gender inequality, ethnic diversity, global health, education, data privacy and more.
In this context, we have seen a spike in stakeholder interest about investments that can drive positive social outcomes. This has been with a view to the shortterm objective of improving the situation related to the public health emergency as well as the long-term objective of helping develop a more pandemic-resilient society. This also feeds into the wider desire to make decisive progress towards
the United Nations Sustainable Development Goals¹.
In this paper, we will highlight a series of approaches adopted by AXA IM and address some of the challenges and opportunities presented.
Not for Retail distribution: This document is intended exclusively for Professional, Institutional, qualified or Wholesale Clients / Investors only, as defined by applicable local laws and regulation. Circulation must be restricted accordingly.
This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized
recommendation to buy or sell securities.
Due to its simplification, this document is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this document is provided based on our state of knowledge at the time of creation of this document. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.
Neither MSCI nor any other party involved in or related to compiling, computing or creating the MSCI data makes any express or implied warranties or representations with respect to such data (or the results to be obtained by the use thereof), and all such parties hereby expressly disclaim all warranties of originality, accuracy, completeness, merchantability or fitness for a particular purpose with respect to any of such data. Without limiting any of the foregoing, in no event shall MSCI, any of its affiliates or any third party involved in or related to compiling, computing or creating the data have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) even if notified of the possibility of such damages. No further distribution or dissemination of the MSCI data is permitted without MSCI’s express written consent.
Issued in the UK by AXA Investment Managers UK Limited, which is authorised and regulated by the Financial Conduct Authority in the UK. Registered in England and Wales No: 01431068. Registered Office: 155 Bishopsgate, London, EC2M 3XJ.
In other jurisdictions, this document is issued by AXA Investment Managers SA’s affiliates in those countries.